Title: FRAGMATIC: A randomised phase III clinical trial investigating the effect of FRAGMin(c) added to standard therapy in patients with lung cancer

Funder
Velindre NHS Trust

Principal Investigator

Project Details
Net value award figure for Cardiff University: £369,863.00
Start date: 01/04/2007
End date: 30/09/2020

Last updated on 2021-28-02 at 06:01